Acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) following treatment for ovarian cancer

被引：0
|
作者：
Gupta, B. [1 ]
Sait, S. N. [1 ]
Block, A. W. [1 ]
Ford, L. A. [1 ]
Moysich, K. B. [1 ]
Baer, M. R. [1 ]
机构：
[1] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
17506
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Maintenance Treatment with 5-Azacitidine for Patients with High Risk Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia Following MDS (MDS-AML) in Complete Remission (CR) after Induction Chemotherapy
    Grovdal, Michael
    Khan, Rasheed
    Aggerholm, Anni
    Antunovic, Petar
    Astermark, Jan
    Bernell, Per
    Engstroem, Lena-Maria
    Kjeldsen, Lars
    Linder, Olle
    Nilsson, Lars
    Olsson, Anna
    Wallvik, Jonas
    Tangen, Jon Magnus
    Oeberg, Gunnar
    Jacobsen, Sten Eirik
    Porwit, Anna
    Hokland, Peter
    Helistrom-Lindberg, Eva
    BLOOD, 2008, 112 (11) : 89 - 89
  • [42] Gfi1 as a novel prognostic marker and for myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) and offers a novel personalized treatment
    Botezatu, L.
    Hoenes, J. M.
    Michel, L.
    Thiede, C.
    van der Reijden, B.
    Heuser, M.
    Makishima, H.
    Thomas, R.
    Jaroslaw, M.
    Ehninger, G.
    Moroy, T.
    Duehrsen, U.
    Khandanpour, C.
    Oncology Research and Treatment, 2015, 38 : 185 - 185
  • [43] ASSESSMENT OF INFECTION EVENTS IN AZACITIDINE (AZA) TREATMENT FOR MYELODYSPLASTIC SYNDROME (MDS) AND ACUTE MYELOID LEUKEMIA (AML). A SINGLE CENTRE EXPERIENCE.
    Romero, P.
    Borras, J. B.
    Serra, F.
    Nigorra, M.
    Del Campo, R.
    Cladera, A.
    Vazquez, I.
    Mascaro, M.
    Gonzalez, E.
    Guerra, J. M.
    Gomez, D.
    Bargay, J.
    HAEMATOLOGICA, 2014, 99 : 196 - 196
  • [44] Interactions and relevance of blast percentage and treatment strategy among younger and older patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)
    DiNardo, Courtney D.
    Garcia-Manero, Guillermo
    Pierce, Sherry
    Nazha, Aziz
    Bueso-Ramos, Carlos
    Jabbour, Elias
    Ravandi, Farhad
    Cortes, Jorge
    Kantarjian, Hagop
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (02) : 227 - 232
  • [45] SUCCESSFUL RE-TREATMENT WITH AZACITIDINE IN A PATIENT WITH MYELODYSPLASTIC SYNDROME (MDS) EVOLUTED INTO ACUTE MYELOID LEUKEMIA (AML) AFTER THE SUSPENSION OF THIS AGENT
    Niscola, P.
    Tendas, A.
    Cupelli, L.
    Scaramucci, L.
    Giovannini, M.
    Fratoni, S.
    de Fabritiis, P.
    LEUKEMIA RESEARCH, 2015, 39 : S137 - S138
  • [46] The pharmacokinetics of azacitidine following subcutaneous treatment in patients with myelodysplastic syndromes (MDS) or acute myelogenous leukemia (AML)
    Laille, E.
    Ward, R.
    Nasser, A.
    Stoltz, M.
    Cogle, C.
    Gore, S.
    Skikne, B. S.
    Garcia-Manero, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [47] Two independent clones in myelodysplastic syndrome following treatment of acute myeloid leukemia
    Masuya, M
    Katayama, N
    Inagaki, K
    Miwa, H
    Hoshino, N
    Hiroyuki, H
    Suzuki, H
    Araki, H
    Mitani, H
    Nishii, K
    Kageyama, S
    Minami, N
    Shiku, H
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 75 (02) : 182 - 186
  • [48] Phase I Study of Bortezomib Combined with Lenalidomide for Relapsed Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Following Hematopoietic Cell Transplantation
    Brunner, Andrew M.
    Blonquist, Traci M.
    McMasters, Malgorzata
    Hobbs, Gabriela S.
    McAfee, Steven L.
    Rosenblatt, Jacalyn
    Amrein, Philip C.
    El-Jawahri, Areej
    Connolly, Christine
    Ramos, Aura
    Mikami, Kaleb
    Logan, Emma
    Dey, Bimalangshu R.
    Spitzer, Thomas
    Avigan, David E.
    Fathi, Amir T.
    Chen, Yi-Bin
    Ballen, Karen
    BLOOD, 2017, 130
  • [49] Two Independent Clones in Myelodysplastic Syndrome Following Treatment of Acute Myeloid Leukemia
    Masahiro Masuya
    Naoyuki Katayama
    Koichi Inagaki
    Hiroshi Miwa
    Natsuki Hoshino
    Hiroyuki Miyashita
    Hirohito Suzuki
    Hiroto Araki
    Hidetsugu Mitani
    Kazuhiro Nishii
    Shin-ichi Kageyama
    Nobuyuki Minami
    Hiroshi Shiku
    International Journal of Hematology, 2002, 75 : 182 - 186
  • [50] Integrated functional proteomic profiling in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML): MDS-like signature is associated with favorable outcome in patients with AML
    Chae, Young Kwang
    Yoo, Suk Young
    Coombes, Kevin R.
    Kornblau, Steven M.
    CANCER RESEARCH, 2014, 74 (19)
12345